483
Caitlin C. Meyer, M.D.Caitlin C. Meyer, M.D. – FDA 483, Dec 21, 2022
Record Details
An FDA inspection of Caitlin C. Meyer, M.D., a clinical investigator in North Miami, FL, revealed significant deficiencies in the conduct of a clinical investigation. Observations included failures in obtaining proper informed consent, maintaining adequate subject case histories, and adhering to the investigational plan, including timely reporting of a serious adverse event. These issues indicate a lack of control over critical aspects of clinical trial management and subject protection.
View Company Profile
ID · 33116e50-c260-4dd0-8f1f-2099ae314885
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.